New Products

Available in UK pharmacies and supermarkets, Panmigrol’s “triple-action formulation” provides more effective migraine relief than standard ibuprofen or sumatriptan tablets, manufacturer Haleon claims.

Navamedic is seeing good early sales for OTC ED treatment Eroxon in multiple Nordic markets after investing in a marketing push which includes a Mission Impossible-inspired commercial.

Stada launches nine new Oilatum products in Saudi Arabia including “rich moisturising creams for intense hydration, gentle body washes for daily cleansing, and baby-specific products like soothing bath bubbles and head-to-toe wash.”

With its new CanesMeno range, Bayer Consumer Health wants to help the estimated 13m women in the UK who are currently perimenopausal or menopausal.

Developed using Datair's Ambee climate data technology, Opella’s Pollen Passport presents users with an easy to use and interactive online visualization of air quality at holiday destinations across the world.

Bayer Consumer Health shelves European launch of topical OTC onychomycosis treatment under its Canesten brand after a Phase III trial of the product - developed by Sweden's Moberg Pharma - failed to meet its primary endpoint.

Reckitt backs up prediction for strong sales during current quarter with advertising featuring a beauty queen and a line extension for Mucinex, one its strongest US consumer health product lines.

FDA’s OTC office director details a 2023 guidance as opening doors for NRT innovation at recent public meeting, but researchers and an industry executive note the most recent approval in the US for an innovative NRT was more than 20 years ago and say FDA isn’t allowing sufficient flexibility for approvals of new products or indications other than cessation related to quitting smoking.